Spinal cord stimulation for refractory angina in patients implanted with cardioverter defibrillators: five case reports

Thomas P Enggaard, Claus Andersen, Christian Scherer

Research output: Contribution to journalJournal articleResearch

Abstract

Patients implanted with a cardioverter defibrillator (ICD) who are suffering from refractory angina pectoris could benefit from spinal cord stimulation (SCS) due to the well-documented pain relieving effect. However, the combined treatment remains controversial. The aim of the study is to report successful long-term treatment with SCS in five patients implanted with cardioverter defibrillators. The combined treatments with ICD and thoracic epidural electrical stimulation were used in five patients with refractory angina pectoris. During the procedure of the implantation, testing with the maximal tolerable level of stimulation was carried out to exclude inference with the ICD. The following treatment with SCS has in all cases been successful, with significant pain relief and improved quality of life. There were no incidences of inappropriate defibrillator shocks. Spinal cord stimulation for refractory angina pectoris can be performed in patients implanted with cardioverter defibrillators without interference. However, individual testing during implantation or re-programming the devices is mandatory in order to assess optimal safety in each patient.
Original languageEnglish
JournalEuropace
Volume12
Issue number9
Pages (from-to)1336-7
Number of pages2
ISSN1099-5129
DOIs
Publication statusPublished - 1. Sep 2010

Fingerprint

Spinal Cord Stimulation
Electric Stimulation
Quality of Life
Safety
Equipment and Supplies
Incidence

Cite this

@article{fe2757c0d79e45668135b514b0b65920,
title = "Spinal cord stimulation for refractory angina in patients implanted with cardioverter defibrillators: five case reports",
abstract = "Patients implanted with a cardioverter defibrillator (ICD) who are suffering from refractory angina pectoris could benefit from spinal cord stimulation (SCS) due to the well-documented pain relieving effect. However, the combined treatment remains controversial. The aim of the study is to report successful long-term treatment with SCS in five patients implanted with cardioverter defibrillators. The combined treatments with ICD and thoracic epidural electrical stimulation were used in five patients with refractory angina pectoris. During the procedure of the implantation, testing with the maximal tolerable level of stimulation was carried out to exclude inference with the ICD. The following treatment with SCS has in all cases been successful, with significant pain relief and improved quality of life. There were no incidences of inappropriate defibrillator shocks. Spinal cord stimulation for refractory angina pectoris can be performed in patients implanted with cardioverter defibrillators without interference. However, individual testing during implantation or re-programming the devices is mandatory in order to assess optimal safety in each patient.",
author = "Enggaard, {Thomas P} and Claus Andersen and Christian Scherer",
year = "2010",
month = "9",
day = "1",
doi = "10.1093/europace/euq093",
language = "English",
volume = "12",
pages = "1336--7",
journal = "Europace",
issn = "1099-5129",
publisher = "Heinemann",
number = "9",

}

Spinal cord stimulation for refractory angina in patients implanted with cardioverter defibrillators: five case reports. / Enggaard, Thomas P; Andersen, Claus; Scherer, Christian.

In: Europace, Vol. 12, No. 9, 01.09.2010, p. 1336-7.

Research output: Contribution to journalJournal articleResearch

TY - JOUR

T1 - Spinal cord stimulation for refractory angina in patients implanted with cardioverter defibrillators: five case reports

AU - Enggaard, Thomas P

AU - Andersen, Claus

AU - Scherer, Christian

PY - 2010/9/1

Y1 - 2010/9/1

N2 - Patients implanted with a cardioverter defibrillator (ICD) who are suffering from refractory angina pectoris could benefit from spinal cord stimulation (SCS) due to the well-documented pain relieving effect. However, the combined treatment remains controversial. The aim of the study is to report successful long-term treatment with SCS in five patients implanted with cardioverter defibrillators. The combined treatments with ICD and thoracic epidural electrical stimulation were used in five patients with refractory angina pectoris. During the procedure of the implantation, testing with the maximal tolerable level of stimulation was carried out to exclude inference with the ICD. The following treatment with SCS has in all cases been successful, with significant pain relief and improved quality of life. There were no incidences of inappropriate defibrillator shocks. Spinal cord stimulation for refractory angina pectoris can be performed in patients implanted with cardioverter defibrillators without interference. However, individual testing during implantation or re-programming the devices is mandatory in order to assess optimal safety in each patient.

AB - Patients implanted with a cardioverter defibrillator (ICD) who are suffering from refractory angina pectoris could benefit from spinal cord stimulation (SCS) due to the well-documented pain relieving effect. However, the combined treatment remains controversial. The aim of the study is to report successful long-term treatment with SCS in five patients implanted with cardioverter defibrillators. The combined treatments with ICD and thoracic epidural electrical stimulation were used in five patients with refractory angina pectoris. During the procedure of the implantation, testing with the maximal tolerable level of stimulation was carried out to exclude inference with the ICD. The following treatment with SCS has in all cases been successful, with significant pain relief and improved quality of life. There were no incidences of inappropriate defibrillator shocks. Spinal cord stimulation for refractory angina pectoris can be performed in patients implanted with cardioverter defibrillators without interference. However, individual testing during implantation or re-programming the devices is mandatory in order to assess optimal safety in each patient.

U2 - 10.1093/europace/euq093

DO - 10.1093/europace/euq093

M3 - Journal article

VL - 12

SP - 1336

EP - 1337

JO - Europace

JF - Europace

SN - 1099-5129

IS - 9

ER -